Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 5.14246680 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 5.14246680 |
3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.59059930 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.55756779 |
5 | L-phenylalanine catabolic process (GO:0006559) | 4.55756779 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.37004122 |
7 | L-phenylalanine metabolic process (GO:0006558) | 4.37004122 |
8 | regulation of cholesterol homeostasis (GO:2000188) | 4.35271785 |
9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21964961 |
10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.07958250 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.07958250 |
12 | urea metabolic process (GO:0019627) | 3.91917315 |
13 | urea cycle (GO:0000050) | 3.91917315 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.82746137 |
15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.80306920 |
16 | lysine metabolic process (GO:0006553) | 3.75350733 |
17 | lysine catabolic process (GO:0006554) | 3.75350733 |
18 | positive regulation of histone deacetylation (GO:0031065) | 3.72244223 |
19 | aromatic amino acid family catabolic process (GO:0009074) | 3.72030339 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.71864198 |
21 | negative regulation of sterol transport (GO:0032372) | 3.71708960 |
22 | negative regulation of cholesterol transport (GO:0032375) | 3.71708960 |
23 | protein retention in ER lumen (GO:0006621) | 3.66118643 |
24 | complement activation, alternative pathway (GO:0006957) | 3.63755311 |
25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61861172 |
26 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.61745744 |
27 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.59816243 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.59644861 |
29 | protein carboxylation (GO:0018214) | 3.55492163 |
30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.55492163 |
31 | valine metabolic process (GO:0006573) | 3.51231875 |
32 | sulfur amino acid catabolic process (GO:0000098) | 3.51035690 |
33 | negative regulation of fibrinolysis (GO:0051918) | 3.50375203 |
34 | cysteine metabolic process (GO:0006534) | 3.49434336 |
35 | kynurenine metabolic process (GO:0070189) | 3.49279083 |
36 | positive thymic T cell selection (GO:0045059) | 3.46939982 |
37 | protein localization to endosome (GO:0036010) | 3.45294869 |
38 | nitrogen cycle metabolic process (GO:0071941) | 3.45153175 |
39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45149246 |
40 | glyoxylate metabolic process (GO:0046487) | 3.32597568 |
41 | proline biosynthetic process (GO:0006561) | 3.32563867 |
42 | regulation of protein activation cascade (GO:2000257) | 3.32449955 |
43 | phospholipid homeostasis (GO:0055091) | 3.31258885 |
44 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.31214911 |
45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.25145486 |
46 | bile acid biosynthetic process (GO:0006699) | 3.24685790 |
47 | phospholipid efflux (GO:0033700) | 3.23304360 |
48 | cellular ketone body metabolic process (GO:0046950) | 3.19004625 |
49 | protein-lipid complex assembly (GO:0065005) | 3.18908815 |
50 | pinocytosis (GO:0006907) | 3.18754946 |
51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17840319 |
52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.17639826 |
53 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15950455 |
54 | regulation of complement activation (GO:0030449) | 3.15158079 |
55 | embryonic process involved in female pregnancy (GO:0060136) | 3.14739995 |
56 | plasma lipoprotein particle clearance (GO:0034381) | 3.14187434 |
57 | plasma lipoprotein particle assembly (GO:0034377) | 3.12196429 |
58 | low-density lipoprotein particle clearance (GO:0034383) | 3.11437224 |
59 | activation of Rac GTPase activity (GO:0032863) | 3.11266831 |
60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10075215 |
61 | regulation of triglyceride catabolic process (GO:0010896) | 3.06616099 |
62 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04213574 |
63 | regulation of fibrinolysis (GO:0051917) | 3.03411186 |
64 | indole-containing compound catabolic process (GO:0042436) | 3.03112549 |
65 | indolalkylamine catabolic process (GO:0046218) | 3.03112549 |
66 | tryptophan catabolic process (GO:0006569) | 3.03112549 |
67 | apoptotic process involved in morphogenesis (GO:0060561) | 3.01040440 |
68 | basement membrane organization (GO:0071711) | 3.00880804 |
69 | ethanol oxidation (GO:0006069) | 3.00161134 |
70 | reverse cholesterol transport (GO:0043691) | 3.00157942 |
71 | regulation of histone H3-K27 methylation (GO:0061085) | 2.98843741 |
72 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.97955488 |
73 | macroautophagy (GO:0016236) | 2.94397257 |
74 | positive regulation of lipid catabolic process (GO:0050996) | 2.94227772 |
75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.93881591 |
76 | negative regulation of cell killing (GO:0031342) | 2.93881591 |
77 | regulation of cholesterol storage (GO:0010885) | 2.92319555 |
78 | regulation of extracellular matrix disassembly (GO:0010715) | 2.91883082 |
79 | amino-acid betaine metabolic process (GO:0006577) | 2.88598816 |
80 | cell-substrate adherens junction assembly (GO:0007045) | 2.88300859 |
81 | focal adhesion assembly (GO:0048041) | 2.88300859 |
82 | bile acid metabolic process (GO:0008206) | 2.87807796 |
83 | positive regulation of nuclease activity (GO:0032075) | 2.86787249 |
84 | cellular modified amino acid catabolic process (GO:0042219) | 2.86291182 |
85 | mannose metabolic process (GO:0006013) | 2.83093171 |
86 | response to laminar fluid shear stress (GO:0034616) | 2.82036829 |
87 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.81651052 |
88 | thymic T cell selection (GO:0045061) | 2.81457873 |
89 | glutamate metabolic process (GO:0006536) | 2.80534581 |
90 | homocysteine metabolic process (GO:0050667) | 2.80534204 |
91 | tricarboxylic acid metabolic process (GO:0072350) | 2.80450524 |
92 | aspartate family amino acid catabolic process (GO:0009068) | 2.79951804 |
93 | cholesterol efflux (GO:0033344) | 2.79442443 |
94 | adherens junction assembly (GO:0034333) | 2.78957841 |
95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77681070 |
96 | tryptophan metabolic process (GO:0006568) | 2.76923107 |
97 | pentose-phosphate shunt (GO:0006098) | 2.76740096 |
98 | acylglycerol homeostasis (GO:0055090) | 2.75500120 |
99 | triglyceride homeostasis (GO:0070328) | 2.75500120 |
100 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.74946321 |
101 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.73936960 |
102 | NIK/NF-kappaB signaling (GO:0038061) | 2.73718553 |
103 | negative regulation of lipid transport (GO:0032369) | 2.73327738 |
104 | ketone body metabolic process (GO:1902224) | 2.72870391 |
105 | modulation by symbiont of host cellular process (GO:0044068) | 2.72568107 |
106 | glucose 6-phosphate metabolic process (GO:0051156) | 2.72071802 |
107 | acetyl-CoA metabolic process (GO:0006084) | 2.71395183 |
108 | response to muramyl dipeptide (GO:0032495) | 2.70762706 |
109 | negative thymic T cell selection (GO:0045060) | 2.70167601 |
110 | positive T cell selection (GO:0043368) | 2.68186550 |
111 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.67326352 |
112 | negative T cell selection (GO:0043383) | 2.66982029 |
113 | cell-substrate junction assembly (GO:0007044) | 2.64933225 |
114 | regulation of lipid catabolic process (GO:0050994) | 2.64917947 |
115 | regulation of sterol transport (GO:0032371) | 2.63170502 |
116 | regulation of cholesterol transport (GO:0032374) | 2.63170502 |
117 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.62062097 |
118 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.61737743 |
119 | negative regulation of cell size (GO:0045792) | 2.61088635 |
120 | regulation of early endosome to late endosome transport (GO:2000641) | 2.61079052 |
121 | intestinal cholesterol absorption (GO:0030299) | 2.61040798 |
122 | protein-lipid complex remodeling (GO:0034368) | 2.60720689 |
123 | macromolecular complex remodeling (GO:0034367) | 2.60720689 |
124 | plasma lipoprotein particle remodeling (GO:0034369) | 2.60720689 |
125 | detection of bacterium (GO:0016045) | 2.59829753 |
126 | regulation of nuclease activity (GO:0032069) | 2.58344741 |
127 | alpha-amino acid catabolic process (GO:1901606) | 2.57966266 |
128 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57933854 |
129 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.57839763 |
130 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.57649239 |
131 | fatty acid homeostasis (GO:0055089) | 2.57326751 |
132 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57047140 |
133 | fatty acid transmembrane transport (GO:1902001) | 2.56940504 |
134 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.56507659 |
135 | detection of other organism (GO:0098543) | 2.55069246 |
136 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.54145455 |
137 | proline metabolic process (GO:0006560) | 2.53315243 |
138 | regulation of fatty acid oxidation (GO:0046320) | 2.53262055 |
139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.52115920 |
140 | drug catabolic process (GO:0042737) | 2.51983070 |
141 | complement activation, classical pathway (GO:0006958) | 2.51934938 |
142 | cholesterol homeostasis (GO:0042632) | 2.50580921 |
143 | protein-lipid complex subunit organization (GO:0071825) | 2.50028849 |
144 | positive regulation of fatty acid oxidation (GO:0046321) | 2.49913855 |
145 | regulation of ARF GTPase activity (GO:0032312) | 2.49822488 |
146 | modulation by virus of host process (GO:0019054) | 2.48966275 |
147 | maternal placenta development (GO:0001893) | 2.46693772 |
148 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44455851 |
149 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43879709 |
150 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.43808534 |
151 | stress fiber assembly (GO:0043149) | 2.43775453 |
152 | vesicle coating (GO:0006901) | 2.43546231 |
153 | positive regulation by symbiont of host defense response (GO:0052509) | 2.43271182 |
154 | modulation by symbiont of host defense response (GO:0052031) | 2.43271182 |
155 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.43271182 |
156 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.43271182 |
157 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.43271182 |
158 | modulation by symbiont of host immune response (GO:0052553) | 2.43271182 |
159 | regulation of extracellular matrix organization (GO:1903053) | 2.43084143 |
160 | ER-nucleus signaling pathway (GO:0006984) | 2.42260761 |
161 | glucose catabolic process (GO:0006007) | 2.42218249 |
162 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.41567268 |
163 | regulation of defense response to virus by virus (GO:0050690) | 2.39462675 |
164 | negative regulation of viral release from host cell (GO:1902187) | 2.39379039 |
165 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.39376095 |
166 | barbed-end actin filament capping (GO:0051016) | 2.37121118 |
167 | regulation of translational fidelity (GO:0006450) | 2.35865115 |
168 | skin morphogenesis (GO:0043589) | 2.35715053 |
169 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.34899193 |
170 | cellular response to unfolded protein (GO:0034620) | 2.34150824 |
171 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.33414524 |
172 | NADPH regeneration (GO:0006740) | 2.33290642 |
173 | response to peptidoglycan (GO:0032494) | 2.32595896 |
174 | negative regulation of fatty acid transport (GO:2000192) | 2.30414325 |
175 | germinal center formation (GO:0002467) | 2.29817248 |
176 | cellular response to virus (GO:0098586) | 2.29151166 |
177 | detection of external biotic stimulus (GO:0098581) | 2.28973095 |
178 | retrograde transport, endosome to Golgi (GO:0042147) | 2.28302740 |
179 | regulation of superoxide anion generation (GO:0032928) | 2.26215005 |
180 | regulation of necroptotic process (GO:0060544) | 2.26089141 |
181 | regulation of chromatin binding (GO:0035561) | 2.25561494 |
182 | snRNA metabolic process (GO:0016073) | 2.24398337 |
183 | activation of MAPKKK activity (GO:0000185) | 2.23273646 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.60688705 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.07202839 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.82735726 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.34268362 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.23088745 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00438817 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.81098250 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 2.63550108 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.42646964 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22634726 |
11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.20553076 |
12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17439963 |
13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.17009530 |
14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.16803581 |
15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.12560856 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12484723 |
17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.12418165 |
18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02524914 |
19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94123034 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91775628 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87607428 |
22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79444924 |
23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77857153 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 1.77107323 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75897400 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.74183574 |
27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.72196368 |
28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68998445 |
29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68378882 |
30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66273081 |
31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63786898 |
32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62988131 |
33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.62565547 |
34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58991213 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57476392 |
36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49337050 |
37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48863855 |
38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48730137 |
39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47475316 |
40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47469811 |
41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.46376235 |
42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45947588 |
43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43740966 |
44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43256593 |
45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42835845 |
46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40457564 |
47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40020475 |
48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39796544 |
49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36616956 |
50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.36522749 |
51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35531989 |
52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35517726 |
53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34759387 |
54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34351654 |
55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33030261 |
56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32634799 |
57 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32596439 |
58 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31221066 |
59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30857689 |
60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30791578 |
61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30457384 |
62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30320795 |
63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30293157 |
64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29485276 |
65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29019834 |
66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28899582 |
67 | MYB_26560356_Chip-Seq_TH1_Human | 1.28667189 |
68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28433673 |
69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27591001 |
70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26138873 |
71 | P68_20966046_ChIP-Seq_HELA_Human | 1.25154581 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24806840 |
73 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.24715355 |
74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24191846 |
75 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23762685 |
76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21720380 |
77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21268720 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20466095 |
79 | MAF_26560356_Chip-Seq_TH2_Human | 1.20042394 |
80 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19778849 |
81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19652345 |
82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19558524 |
83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19544057 |
84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19241317 |
85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19210880 |
86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18725931 |
87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17231526 |
88 | MYB_26560356_Chip-Seq_TH2_Human | 1.16819751 |
89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16486058 |
90 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16393453 |
91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15960774 |
92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15510137 |
93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15055169 |
94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15038101 |
95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14823931 |
96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14620517 |
97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14481972 |
98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14388754 |
99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12828696 |
100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12748077 |
101 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11381788 |
102 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10776290 |
103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10181768 |
104 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09648135 |
105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09461651 |
106 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07887116 |
107 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07784039 |
108 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07398530 |
109 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07203202 |
110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05583092 |
111 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04804173 |
112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03935031 |
113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03532649 |
114 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02770912 |
115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02290192 |
116 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02215011 |
117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02016624 |
118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01853816 |
119 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01042367 |
120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00760541 |
121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00760541 |
122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00705473 |
123 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00578437 |
124 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00228568 |
125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00021957 |
126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99736007 |
127 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99444465 |
128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99032574 |
129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97521732 |
130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97413690 |
131 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.96751488 |
132 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96654379 |
133 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96203259 |
134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95737152 |
135 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95597755 |
136 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95186763 |
137 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95101319 |
138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94617621 |
139 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94481950 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.95698225 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.81482582 |
3 | MP0005365_abnormal_bile_salt | 3.76684268 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.25211781 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.07598881 |
6 | MP0009840_abnormal_foam_cell | 2.89809541 |
7 | MP0008260_abnormal_autophagy | 2.87278718 |
8 | MP0003252_abnormal_bile_duct | 2.86102115 |
9 | MP0003300_gastrointestinal_ulcer | 2.84496137 |
10 | MP0010329_abnormal_lipoprotein_level | 2.63653975 |
11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58944434 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.57728517 |
13 | MP0005083_abnormal_biliary_tract | 2.33892271 |
14 | MP0008961_abnormal_basal_metabolism | 2.18207910 |
15 | MP0001666_abnormal_nutrient_absorption | 2.05385045 |
16 | MP0000609_abnormal_liver_physiology | 2.00166020 |
17 | MP0002877_abnormal_melanocyte_morpholog | 1.96397566 |
18 | MP0000858_altered_metastatic_potential | 1.92715566 |
19 | MP0005670_abnormal_white_adipose | 1.77653198 |
20 | MP0000604_amyloidosis | 1.74564807 |
21 | MP0000685_abnormal_immune_system | 1.73267581 |
22 | MP0004858_abnormal_nervous_system | 1.70937310 |
23 | MP0003303_peritoneal_inflammation | 1.70660802 |
24 | MP0010234_abnormal_vibrissa_follicle | 1.67355409 |
25 | MP0002118_abnormal_lipid_homeostasis | 1.65557596 |
26 | MP0004947_skin_inflammation | 1.65458400 |
27 | MP0004130_abnormal_muscle_cell | 1.62138517 |
28 | MP0009333_abnormal_splenocyte_physiolog | 1.53958539 |
29 | MP0003172_abnormal_lysosome_physiology | 1.52322763 |
30 | MP0002166_altered_tumor_susceptibility | 1.50923132 |
31 | MP0002138_abnormal_hepatobiliary_system | 1.49742852 |
32 | MP0003806_abnormal_nucleotide_metabolis | 1.48961311 |
33 | MP0005332_abnormal_amino_acid | 1.47818780 |
34 | MP0003436_decreased_susceptibility_to | 1.46573996 |
35 | MP0005058_abnormal_lysosome_morphology | 1.44887356 |
36 | MP0002396_abnormal_hematopoietic_system | 1.44841203 |
37 | MP0003329_amyloid_beta_deposits | 1.43102670 |
38 | MP0001873_stomach_inflammation | 1.41635244 |
39 | MP0004185_abnormal_adipocyte_glucose | 1.39622913 |
40 | MP0005076_abnormal_cell_differentiation | 1.38335830 |
41 | MP0005666_abnormal_adipose_tissue | 1.36180512 |
42 | MP0004233_abnormal_muscle_weight | 1.35583685 |
43 | MP0005464_abnormal_platelet_physiology | 1.33848618 |
44 | MP0003656_abnormal_erythrocyte_physiolo | 1.30298203 |
45 | MP0000569_abnormal_digit_pigmentation | 1.27409117 |
46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24355391 |
47 | MP0001800_abnormal_humoral_immune | 1.24221917 |
48 | MP0005319_abnormal_enzyme/_coenzyme | 1.22799180 |
49 | MP0001790_abnormal_immune_system | 1.22780978 |
50 | MP0005387_immune_system_phenotype | 1.22780978 |
51 | MP0005375_adipose_tissue_phenotype | 1.22157805 |
52 | MP0001533_abnormal_skeleton_physiology | 1.21244055 |
53 | MP0004272_abnormal_basement_membrane | 1.21207288 |
54 | MP0009643_abnormal_urine_homeostasis | 1.20969289 |
55 | MP0005409_darkened_coat_color | 1.20914201 |
56 | MP0003763_abnormal_thymus_physiology | 1.20549920 |
57 | MP0009278_abnormal_bone_marrow | 1.20146901 |
58 | MP0004264_abnormal_extraembryonic_tissu | 1.19361167 |
59 | MP0001915_intracranial_hemorrhage | 1.18619616 |
60 | MP0001348_abnormal_lacrimal_gland | 1.16837447 |
61 | MP0010352_gastrointestinal_tract_polyps | 1.16760459 |
62 | MP0001853_heart_inflammation | 1.16299781 |
63 | MP0002254_reproductive_system_inflammat | 1.16152515 |
64 | MP0002089_abnormal_postnatal_growth/wei | 1.16128536 |
65 | MP0000678_abnormal_parathyroid_gland | 1.15863574 |
66 | MP0002060_abnormal_skin_morphology | 1.13808754 |
67 | MP0004510_myositis | 1.12806525 |
68 | MP0003045_fibrosis | 1.10361854 |
69 | MP0003183_abnormal_peptide_metabolism | 1.10281123 |
70 | MP0001661_extended_life_span | 1.10206744 |
71 | MP0000598_abnormal_liver_morphology | 1.10189377 |
72 | MP0005621_abnormal_cell_physiology | 1.08414764 |
73 | MP0002998_abnormal_bone_remodeling | 1.07027932 |
74 | MP0005257_abnormal_intraocular_pressure | 1.06935724 |
75 | MP0003279_aneurysm | 1.05081212 |
76 | MP0004808_abnormal_hematopoietic_stem | 1.05004070 |
77 | MP0005501_abnormal_skin_physiology | 1.03487278 |
78 | MP0000003_abnormal_adipose_tissue | 1.01261609 |
79 | MP0002971_abnormal_brown_adipose | 0.99800796 |
80 | MP0003566_abnormal_cell_adhesion | 0.97801744 |
81 | MP0001730_embryonic_growth_arrest | 0.97649690 |
82 | MP0001958_emphysema | 0.97376102 |
83 | MP0002796_impaired_skin_barrier | 0.97062781 |
84 | MP0002909_abnormal_adrenal_gland | 0.96068307 |
85 | MP0008469_abnormal_protein_level | 0.95255039 |
86 | MP0003075_altered_response_to | 0.95033508 |
87 | MP0002933_joint_inflammation | 0.94397367 |
88 | MP0000703_abnormal_thymus_morphology | 0.93560582 |
89 | MP0003866_abnormal_defecation | 0.93310327 |
90 | MP0002405_respiratory_system_inflammati | 0.92954329 |
91 | MP0001835_abnormal_antigen_presentation | 0.91833387 |
92 | MP0002429_abnormal_blood_cell | 0.91693375 |
93 | MP0003868_abnormal_feces_composition | 0.90198385 |
94 | MP0010155_abnormal_intestine_physiology | 0.89738843 |
95 | MP0005023_abnormal_wound_healing | 0.87749271 |
96 | MP0003111_abnormal_nucleus_morphology | 0.87391921 |
97 | MP0003283_abnormal_digestive_organ | 0.87230444 |
98 | MP0000733_abnormal_muscle_development | 0.87068989 |
99 | MP0009780_abnormal_chondrocyte_physiolo | 0.87068022 |
100 | MP0000751_myopathy | 0.86517227 |
101 | MP0002723_abnormal_immune_serum | 0.86133000 |
102 | MP0005334_abnormal_fat_pad | 0.85509265 |
103 | MP0004381_abnormal_hair_follicle | 0.85454319 |
104 | MP0009763_increased_sensitivity_to | 0.84906525 |
105 | MP0000490_abnormal_crypts_of | 0.84847029 |
106 | MP0000747_muscle_weakness | 0.84325538 |
107 | MP0002452_abnormal_antigen_presenting | 0.83200449 |
108 | MP0001845_abnormal_inflammatory_respons | 0.82759246 |
109 | MP0000767_abnormal_smooth_muscle | 0.80930467 |
110 | MP0002398_abnormal_bone_marrow | 0.80887324 |
111 | MP0001851_eye_inflammation | 0.79907927 |
112 | MP0003690_abnormal_glial_cell | 0.79833770 |
113 | MP0009931_abnormal_skin_appearance | 0.79640966 |
114 | MP0003453_abnormal_keratinocyte_physiol | 0.79298819 |
115 | MP0001216_abnormal_epidermal_layer | 0.78761970 |
116 | MP0004019_abnormal_vitamin_homeostasis | 0.78718077 |
117 | MP0001849_ear_inflammation | 0.78594158 |
118 | MP0006082_CNS_inflammation | 0.78496188 |
119 | MP0002078_abnormal_glucose_homeostasis | 0.78466351 |
120 | MP0005025_abnormal_response_to | 0.78272011 |
121 | MP0002136_abnormal_kidney_physiology | 0.78269354 |
122 | MP0002928_abnormal_bile_duct | 0.78049257 |
123 | MP0002132_abnormal_respiratory_system | 0.77751483 |
124 | MP0002420_abnormal_adaptive_immunity | 0.77703752 |
125 | MP0009785_altered_susceptibility_to | 0.77536282 |
126 | MP0003195_calcinosis | 0.77512726 |
127 | MP0002970_abnormal_white_adipose | 0.75880474 |
128 | MP0001819_abnormal_immune_cell | 0.75865173 |
129 | MP0008874_decreased_physiological_sensi | 0.75475078 |
130 | MP0002006_tumorigenesis | 0.75130443 |
131 | MP0005000_abnormal_immune_tolerance | 0.74249551 |
132 | MP0000689_abnormal_spleen_morphology | 0.74231801 |
133 | MP0002419_abnormal_innate_immunity | 0.74048385 |
134 | MP0000716_abnormal_immune_system | 0.72676500 |
135 | MP0003091_abnormal_cell_migration | 0.71638943 |
136 | MP0005451_abnormal_body_composition | 0.71385736 |
137 | MP0002722_abnormal_immune_system | 0.69881384 |
138 | MP0009642_abnormal_blood_homeostasis | 0.69743883 |
139 | MP0008438_abnormal_cutaneous_collagen | 0.69603193 |
140 | MP0001756_abnormal_urination | 0.69156727 |
141 | MP0005397_hematopoietic_system_phenotyp | 0.68362761 |
142 | MP0001545_abnormal_hematopoietic_system | 0.68362761 |
143 | MP0001765_abnormal_ion_homeostasis | 0.68254795 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.89430810 |
2 | Xanthomatosis (HP:0000991) | 3.84339273 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.58689231 |
4 | Complement deficiency (HP:0004431) | 3.54640677 |
5 | Intrahepatic cholestasis (HP:0001406) | 3.46818139 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37187732 |
7 | Protrusio acetabuli (HP:0003179) | 3.11009920 |
8 | Vertebral compression fractures (HP:0002953) | 3.07661098 |
9 | Cerebral aneurysm (HP:0004944) | 2.99582289 |
10 | Premature rupture of membranes (HP:0001788) | 2.96092362 |
11 | Broad face (HP:0000283) | 2.91735533 |
12 | Hyperlipoproteinemia (HP:0010980) | 2.87089053 |
13 | Nasal polyposis (HP:0100582) | 2.87028566 |
14 | Myocardial infarction (HP:0001658) | 2.86631332 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 2.85536227 |
16 | Cervical subluxation (HP:0003308) | 2.74226748 |
17 | Mitral stenosis (HP:0001718) | 2.69644123 |
18 | Hypobetalipoproteinemia (HP:0003563) | 2.69368964 |
19 | Ketosis (HP:0001946) | 2.68283346 |
20 | Abnormality of complement system (HP:0005339) | 2.65610907 |
21 | Eczematoid dermatitis (HP:0000976) | 2.64049756 |
22 | Epidermoid cyst (HP:0200040) | 2.60631366 |
23 | Abnormality of the nasal mucosa (HP:0000433) | 2.58565791 |
24 | Hypercholesterolemia (HP:0003124) | 2.56986222 |
25 | Distal lower limb amyotrophy (HP:0008944) | 2.55733035 |
26 | Increased connective tissue (HP:0009025) | 2.54173617 |
27 | Flat acetabular roof (HP:0003180) | 2.49408377 |
28 | Cellulitis (HP:0100658) | 2.47211781 |
29 | Hyperacusis (HP:0010780) | 2.43645106 |
30 | Prolonged partial thromboplastin time (HP:0003645) | 2.43471962 |
31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.43017321 |
32 | Biconcave vertebral bodies (HP:0004586) | 2.42489157 |
33 | Hypoalphalipoproteinemia (HP:0003233) | 2.40413890 |
34 | Distal upper limb amyotrophy (HP:0007149) | 2.33255452 |
35 | Upper limb amyotrophy (HP:0009129) | 2.33255452 |
36 | Achilles tendon contracture (HP:0001771) | 2.33049906 |
37 | Thin bony cortex (HP:0002753) | 2.32835416 |
38 | J-shaped sella turcica (HP:0002680) | 2.32203569 |
39 | Hypolipoproteinemia (HP:0010981) | 2.31585297 |
40 | Joint hemorrhage (HP:0005261) | 2.31237806 |
41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30523041 |
42 | Macroorchidism (HP:0000053) | 2.30001022 |
43 | Hyperammonemia (HP:0001987) | 2.28348664 |
44 | Hemorrhage of the eye (HP:0011885) | 2.27882088 |
45 | Hand muscle atrophy (HP:0009130) | 2.26067007 |
46 | Abnormality of the lower motor neuron (HP:0002366) | 2.24905309 |
47 | Polycythemia (HP:0001901) | 2.24171941 |
48 | Mucopolysacchariduria (HP:0008155) | 2.20445343 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20445343 |
50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13752851 |
51 | Spastic diplegia (HP:0001264) | 2.13193582 |
52 | Skin nodule (HP:0200036) | 2.12668157 |
53 | Aneurysm (HP:0002617) | 2.11254215 |
54 | Long toe (HP:0010511) | 2.09904382 |
55 | Aortic aneurysm (HP:0004942) | 2.09263577 |
56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08846280 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08846280 |
58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08846280 |
59 | Reticulocytosis (HP:0001923) | 2.08756833 |
60 | Global brain atrophy (HP:0002283) | 2.08351358 |
61 | Dilatation of the ascending aorta (HP:0005111) | 2.06596750 |
62 | Abnormality of macrophages (HP:0004311) | 2.06309169 |
63 | Interstitial pulmonary disease (HP:0006530) | 2.04996105 |
64 | Increased IgE level (HP:0003212) | 2.02803771 |
65 | Abnormality of the Achilles tendon (HP:0005109) | 2.02477084 |
66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01523134 |
67 | Acanthocytosis (HP:0001927) | 2.00908860 |
68 | Distal lower limb muscle weakness (HP:0009053) | 2.00819575 |
69 | Ketoacidosis (HP:0001993) | 2.00737780 |
70 | Papilloma (HP:0012740) | 1.98368772 |
71 | Verrucae (HP:0200043) | 1.98368772 |
72 | Ulnar bowing (HP:0003031) | 1.97586465 |
73 | Long palpebral fissure (HP:0000637) | 1.97157390 |
74 | Gingival bleeding (HP:0000225) | 1.97028039 |
75 | Mitral valve prolapse (HP:0001634) | 1.96495867 |
76 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96010767 |
77 | Obstructive sleep apnea (HP:0002870) | 1.95715814 |
78 | Heterotopia (HP:0002282) | 1.93100457 |
79 | Turricephaly (HP:0000262) | 1.92357840 |
80 | Short nail (HP:0001799) | 1.91805573 |
81 | Hypoglycemic coma (HP:0001325) | 1.91145986 |
82 | Systemic lupus erythematosus (HP:0002725) | 1.90532532 |
83 | Striae distensae (HP:0001065) | 1.90239406 |
84 | Back pain (HP:0003418) | 1.90055946 |
85 | Pseudobulbar signs (HP:0002200) | 1.90041667 |
86 | Cerebral inclusion bodies (HP:0100314) | 1.88553471 |
87 | Cholelithiasis (HP:0001081) | 1.87559914 |
88 | Disproportionate tall stature (HP:0001519) | 1.87367940 |
89 | Broad metatarsal (HP:0001783) | 1.86932534 |
90 | Cholecystitis (HP:0001082) | 1.85891362 |
91 | Abnormal gallbladder physiology (HP:0012438) | 1.85891362 |
92 | Gastrointestinal infarctions (HP:0005244) | 1.85154425 |
93 | Abnormality of the thoracic spine (HP:0100711) | 1.84388163 |
94 | Increased CSF protein (HP:0002922) | 1.84256718 |
95 | Insomnia (HP:0100785) | 1.83918218 |
96 | Metaphyseal cupping (HP:0003021) | 1.83685427 |
97 | Esophageal varix (HP:0002040) | 1.83056315 |
98 | Hypertensive crisis (HP:0100735) | 1.83041192 |
99 | Blue sclerae (HP:0000592) | 1.82874728 |
100 | Dysmetric saccades (HP:0000641) | 1.82624942 |
101 | Lymphangioma (HP:0100764) | 1.81533395 |
102 | Asymmetry of the thorax (HP:0001555) | 1.81475681 |
103 | Neonatal onset (HP:0003623) | 1.81111899 |
104 | Ankyloglossia (HP:0010296) | 1.80643694 |
105 | Chronic otitis media (HP:0000389) | 1.80270767 |
106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78860763 |
107 | Increased mean platelet volume (HP:0011877) | 1.78594620 |
108 | Abnormal gallbladder morphology (HP:0012437) | 1.78130345 |
109 | Recurrent viral infections (HP:0004429) | 1.78073900 |
110 | Hyperbilirubinemia (HP:0002904) | 1.78015126 |
111 | Abnormal platelet volume (HP:0011876) | 1.76191284 |
112 | Autoimmune thrombocytopenia (HP:0001973) | 1.76034105 |
113 | Hepatocellular carcinoma (HP:0001402) | 1.75373492 |
114 | Difficulty climbing stairs (HP:0003551) | 1.75266365 |
115 | Polygenic inheritance (HP:0010982) | 1.75251656 |
116 | Peritonitis (HP:0002586) | 1.75166873 |
117 | Sensorimotor neuropathy (HP:0007141) | 1.75155674 |
118 | Late onset (HP:0003584) | 1.74895555 |
119 | Fat malabsorption (HP:0002630) | 1.74765535 |
120 | Hypertriglyceridemia (HP:0002155) | 1.74744891 |
121 | Spinal cord lesions (HP:0100561) | 1.74528975 |
122 | Syringomyelia (HP:0003396) | 1.74528975 |
123 | Abnormality of the fingertips (HP:0001211) | 1.74050811 |
124 | Abnormality of oral frenula (HP:0000190) | 1.74008800 |
125 | T lymphocytopenia (HP:0005403) | 1.73927689 |
126 | Recurrent abscess formation (HP:0002722) | 1.73660564 |
127 | Menorrhagia (HP:0000132) | 1.73465157 |
128 | Recurrent bronchitis (HP:0002837) | 1.72929819 |
129 | Gingivitis (HP:0000230) | 1.72794610 |
130 | Amyloidosis (HP:0011034) | 1.72694822 |
131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72434255 |
132 | Renovascular hypertension (HP:0100817) | 1.72045834 |
133 | Poikilocytosis (HP:0004447) | 1.72013076 |
134 | Fragile skin (HP:0001030) | 1.71843204 |
135 | Abnormality of purine metabolism (HP:0004352) | 1.71225850 |
136 | Mitral regurgitation (HP:0001653) | 1.70092812 |
137 | Stroke (HP:0001297) | 1.70009276 |
138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69538145 |
139 | Emphysema (HP:0002097) | 1.68541746 |
140 | Pustule (HP:0200039) | 1.68192261 |
141 | Entropion (HP:0000621) | 1.68102722 |
142 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67937945 |
143 | Loss of speech (HP:0002371) | 1.67877780 |
144 | Hyporeflexia of lower limbs (HP:0002600) | 1.67699297 |
145 | Ectopia lentis (HP:0001083) | 1.67218493 |
146 | Neoplasm of the heart (HP:0100544) | 1.66735185 |
147 | Increased serum ferritin (HP:0003281) | 1.66724543 |
148 | Impaired platelet aggregation (HP:0003540) | 1.66658518 |
149 | Abnormal platelet function (HP:0011869) | 1.66658518 |
150 | Fatigue (HP:0012378) | 1.66483071 |
151 | Purpura (HP:0000979) | 1.66100954 |
152 | Recurrent bacterial skin infections (HP:0005406) | 1.66097834 |
153 | Dysostosis multiplex (HP:0000943) | 1.66029884 |
154 | Frequent falls (HP:0002359) | 1.65932777 |
155 | Axonal loss (HP:0003447) | 1.65138590 |
156 | Neuronal loss in central nervous system (HP:0002529) | 1.64597708 |
157 | Elevated alkaline phosphatase (HP:0003155) | 1.64496345 |
158 | Wormian bones (HP:0002645) | 1.63659257 |
159 | Stridor (HP:0010307) | 1.63534935 |
160 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.63381628 |
161 | Dislocated radial head (HP:0003083) | 1.62033858 |
162 | Atrophic scars (HP:0001075) | 1.61902824 |
163 | Arterial tortuosity (HP:0005116) | 1.61726894 |
164 | Lower limb amyotrophy (HP:0007210) | 1.60185204 |
165 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.59962716 |
166 | Osteolytic defects of the hand bones (HP:0009699) | 1.59962716 |
167 | Ragged-red muscle fibers (HP:0003200) | 1.59770702 |
168 | Nuclear cataract (HP:0100018) | 1.59075274 |
169 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.58658039 |
170 | Obstructive lung disease (HP:0006536) | 1.58199462 |
171 | Chronic obstructive pulmonary disease (HP:0006510) | 1.58199462 |
172 | Easy fatigability (HP:0003388) | 1.57817490 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.25077108 |
2 | ERN1 | 3.40661877 |
3 | MAP3K10 | 3.34422867 |
4 | SMG1 | 3.18308153 |
5 | PKN2 | 3.13015387 |
6 | EEF2K | 3.05122892 |
7 | PRPF4B | 3.00117218 |
8 | SIK1 | 2.81720000 |
9 | FGFR4 | 2.76835063 |
10 | MAP4K1 | 2.71617767 |
11 | IRAK3 | 2.25623002 |
12 | PTK6 | 2.01435715 |
13 | RIPK1 | 1.87773110 |
14 | TYK2 | 1.85941730 |
15 | GRK6 | 1.73478993 |
16 | ICK | 1.72699753 |
17 | EPHB1 | 1.71407101 |
18 | SIK2 | 1.65162817 |
19 | RIPK4 | 1.64170641 |
20 | TTN | 1.63262098 |
21 | MAP3K13 | 1.62695909 |
22 | JAK1 | 1.62309525 |
23 | MAP3K7 | 1.55564517 |
24 | CAMK1G | 1.51109399 |
25 | NME2 | 1.51038019 |
26 | EPHA2 | 1.49170572 |
27 | STK10 | 1.42187842 |
28 | MAP3K3 | 1.32539489 |
29 | CAMK1D | 1.31801037 |
30 | TAOK1 | 1.31551864 |
31 | TBK1 | 1.27517736 |
32 | BCKDK | 1.25262353 |
33 | LRRK2 | 1.24952802 |
34 | JAK3 | 1.23784069 |
35 | PDGFRA | 1.21735270 |
36 | SIK3 | 1.21088719 |
37 | TAOK3 | 1.20308580 |
38 | ZAP70 | 1.14449056 |
39 | CDK12 | 1.12056750 |
40 | KSR2 | 1.12038316 |
41 | JAK2 | 1.10806909 |
42 | IRAK4 | 1.10641106 |
43 | MAP3K11 | 1.10508814 |
44 | PRKCH | 1.09527101 |
45 | ITK | 1.07756403 |
46 | FGFR3 | 1.05273220 |
47 | RET | 1.04200863 |
48 | TGFBR2 | 1.03308304 |
49 | TAOK2 | 1.00970143 |
50 | MAP2K3 | 0.98503904 |
51 | FGFR2 | 0.96269580 |
52 | MTOR | 0.96140323 |
53 | TYRO3 | 0.95400269 |
54 | CDC42BPA | 0.93154538 |
55 | IKBKE | 0.88256480 |
56 | CSK | 0.87705546 |
57 | HCK | 0.85864333 |
58 | DYRK1B | 0.85532382 |
59 | MAP3K6 | 0.84420058 |
60 | PIM2 | 0.83823331 |
61 | BLK | 0.82154880 |
62 | CAMKK1 | 0.81864628 |
63 | MAPK11 | 0.80693800 |
64 | PDK1 | 0.79106382 |
65 | CSF1R | 0.78449773 |
66 | PRKD3 | 0.77430545 |
67 | ALK | 0.77364026 |
68 | MAP3K8 | 0.75656253 |
69 | PTK2 | 0.74761930 |
70 | ARAF | 0.74184007 |
71 | BMX | 0.74152790 |
72 | SCYL2 | 0.71866940 |
73 | FLT3 | 0.70663711 |
74 | MARK2 | 0.70143886 |
75 | PDGFRB | 0.70053526 |
76 | EPHA3 | 0.68854488 |
77 | PDPK1 | 0.64773782 |
78 | PAK6 | 0.62872382 |
79 | PAK2 | 0.62390727 |
80 | CDK6 | 0.61243672 |
81 | PDK4 | 0.60725739 |
82 | PDK3 | 0.60725739 |
83 | MAP3K9 | 0.60040404 |
84 | MET | 0.59503591 |
85 | MAP3K1 | 0.59115915 |
86 | IRAK2 | 0.58911248 |
87 | BTK | 0.58795915 |
88 | SYK | 0.57914696 |
89 | DAPK2 | 0.56035581 |
90 | SGK3 | 0.54647550 |
91 | PRKD1 | 0.54645237 |
92 | DDR2 | 0.54313188 |
93 | LCK | 0.53918958 |
94 | CDK7 | 0.53601709 |
95 | CDK4 | 0.52687274 |
96 | HIPK2 | 0.52483754 |
97 | TNK2 | 0.51442321 |
98 | MOS | 0.51342249 |
99 | KIT | 0.51338466 |
100 | MAP3K14 | 0.50731751 |
101 | NTRK1 | 0.50537111 |
102 | MAPK15 | 0.50041847 |
103 | TESK2 | 0.49237530 |
104 | PTK2B | 0.49170426 |
105 | BRAF | 0.49023008 |
106 | DMPK | 0.48356729 |
107 | RAF1 | 0.47603905 |
108 | MAPK12 | 0.47512443 |
109 | FES | 0.47358330 |
110 | RPS6KA2 | 0.46882656 |
111 | RPS6KC1 | 0.46515568 |
112 | RPS6KL1 | 0.46515568 |
113 | PRKCQ | 0.46035398 |
114 | MAP2K2 | 0.45407800 |
115 | FGR | 0.45173335 |
116 | PRKAA2 | 0.43772503 |
117 | NEK2 | 0.43252097 |
118 | STK11 | 0.42484043 |
119 | MAPKAPK2 | 0.40996832 |
120 | PAK4 | 0.40579107 |
121 | FYN | 0.39854711 |
122 | PRKD2 | 0.39683126 |
123 | EGFR | 0.39514460 |
124 | TESK1 | 0.39057125 |
125 | RPS6KB2 | 0.38942937 |
126 | MST1R | 0.38770290 |
127 | CHUK | 0.38449687 |
128 | PIK3CG | 0.38326786 |
129 | LMTK2 | 0.37402412 |
130 | PRKAA1 | 0.36225187 |
131 | MAP3K2 | 0.36160508 |
132 | KDR | 0.36078912 |
133 | MAP2K6 | 0.32807946 |
134 | MAPK7 | 0.31880089 |
135 | MARK3 | 0.29306068 |
136 | NEK9 | 0.28590092 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70237724 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.54832105 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.99196045 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98135555 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51794913 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44289312 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00262557 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93927185 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88661891 |
10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87205391 |
11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81148223 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75522832 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73032791 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72069794 |
15 | Bile secretion_Homo sapiens_hsa04976 | 1.70971614 |
16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69514492 |
17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.60651116 |
18 | Lysine degradation_Homo sapiens_hsa00310 | 1.57316849 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56872077 |
20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.56841952 |
21 | Bladder cancer_Homo sapiens_hsa05219 | 1.49087296 |
22 | ABC transporters_Homo sapiens_hsa02010 | 1.46733587 |
23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45278118 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44673850 |
25 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.44248154 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43679245 |
27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37105692 |
28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31956102 |
29 | Thyroid cancer_Homo sapiens_hsa05216 | 1.30950540 |
30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28897911 |
31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26793246 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26496924 |
33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26129502 |
34 | Insulin resistance_Homo sapiens_hsa04931 | 1.19725603 |
35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16727487 |
36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15985764 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15630856 |
38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14677763 |
39 | Influenza A_Homo sapiens_hsa05164 | 1.11821913 |
40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11329463 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.11113721 |
42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10909685 |
43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09739399 |
44 | Apoptosis_Homo sapiens_hsa04210 | 1.07747500 |
45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06264591 |
46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04256977 |
47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04154551 |
48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02272292 |
49 | Lysosome_Homo sapiens_hsa04142 | 1.01869807 |
50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99432027 |
51 | Peroxisome_Homo sapiens_hsa04146 | 0.99040397 |
52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96508647 |
53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95789398 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94108272 |
55 | Shigellosis_Homo sapiens_hsa05131 | 0.93500344 |
56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92270317 |
57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92001262 |
58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91911720 |
59 | Measles_Homo sapiens_hsa05162 | 0.91754413 |
60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89199109 |
61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88263245 |
62 | Focal adhesion_Homo sapiens_hsa04510 | 0.87843039 |
63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87307392 |
64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86974108 |
65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86148748 |
66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85322786 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84035358 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83963866 |
69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83784003 |
70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83783079 |
71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83687110 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.83603363 |
73 | Tuberculosis_Homo sapiens_hsa05152 | 0.82334173 |
74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82184493 |
75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81987374 |
76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81198822 |
77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80777564 |
78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79184037 |
79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79033412 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.78564486 |
81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78376436 |
82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78239497 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77087817 |
84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76642660 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75565294 |
86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75477785 |
87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73967496 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73888287 |
89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73612197 |
90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71810199 |
91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70975016 |
92 | Salmonella infection_Homo sapiens_hsa05132 | 0.70549728 |
93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70447720 |
94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70286201 |
95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69138684 |
96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68596001 |
97 | Prostate cancer_Homo sapiens_hsa05215 | 0.68291433 |
98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66332040 |
99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66293604 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66290026 |
101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66234399 |
102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65519239 |
103 | Pertussis_Homo sapiens_hsa05133 | 0.65375783 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65231510 |
105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64479854 |
106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64025094 |
107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64016269 |
108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63836796 |
109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63167995 |
110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62194768 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60006031 |
112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59947372 |
113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59481567 |
114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59030263 |
115 | Malaria_Homo sapiens_hsa05144 | 0.58977107 |
116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57031814 |
117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55939128 |
118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55383762 |
119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54217159 |
120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53519429 |
121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52808252 |
122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52621593 |
123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52409132 |
124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50784326 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49543740 |
126 | Adherens junction_Homo sapiens_hsa04520 | 0.49530880 |
127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48436776 |
128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48111954 |
129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45196242 |
130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44736096 |
131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44403542 |
132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44093355 |
133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43979166 |
134 | Prion diseases_Homo sapiens_hsa05020 | 0.42273531 |
135 | Glioma_Homo sapiens_hsa05214 | 0.42257123 |
136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41737008 |
137 | Platelet activation_Homo sapiens_hsa04611 | 0.41524043 |
138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40671830 |
139 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39698429 |
140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38932503 |
141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37739086 |
142 | Hepatitis C_Homo sapiens_hsa05160 | 0.37036106 |
143 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36419182 |
144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36384828 |
145 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35805202 |
146 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34567356 |
147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34414216 |
148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32489668 |
149 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31270045 |
150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31037590 |